You are here: Home » Markets » News
Business Standard

MARKET WRAP: Sensex ends 209 pts up, Nifty at 10,843 post Trump-Kim meeting

Among sectoral indices, the Nifty Pharma index ended over 2.5% higher led by a rise in the shares of Lupin, Dr. Reddy's Laboratories and Glenmark Pharmaceuticals.

SI Reporter  |  New Delhi 

MARKET COMMENT Jayant Manglik, President, Religare Broking After some consolidation, the Indian equity benchmark indices ended Tuesday’s session on a strong note, with the Nifty closing at 10,843 levels, up 56 points or 0.5%. Amongst the broader market indices, BSE Midcap outperformed, with gains of 0.9%, whereas BSE Smallcap closed in-line with benchmark. Barring Metals and Telecom, all the other sectoral indices ended in green with Banks, Capital Goods, FMCG and IT being the top performers. Amongst the global indices, European markets were trading lower, while Asian markets closed on a mixed note.   Going forward, market participants would be actively tracking global developments, progress of monsoon, currency movement and crude oil prices. Furthermore, FOMC meet outcome scheduled tomorrow will be crucial and it would dictate further course of market. We expect volatility to remain high in the near term and hence would advise investors to stick to only fundamentally sound companies Nifty Pharma index ends 2.58% higher. Top gainers: COMPANY LATEST PREV CLOSE GAIN() GAIN(%) LUPIN 855.00 809.50 45.50 5.62 DR REDDY'S LABS 2190.65 2083.20 107.45 5.16 GLENMARK PHARMA. 588.05 564.40 23.65 4.19 DIVI'S LAB. 1064.15 1024.60 39.55 3.86 AUROBINDO PHARMA 595.55 576.45 19.10 3.31 Nifty sectoral gainers of the day BSE Sensex: Dr. Reddy's, SBI among top gainers of the day; Bharti Airtel top loser Market at close   The S&P BSE Sensex ended at 35,693, up 209 points while the broader Nifty50 index settled at 10,843, up 56 points. HIGHLIGHTS BofA Merrill Lynch June Fund Manager Survey  ·       Average cash balance ticks down to 4.8% in June, from 4.9% in May, but still above the 10-year average of 4.5%   ·       Allocation to US equities climbs 16ppt to net 1% overweight, the first time investors surveyed have gone overweight in 15 months   ·       64% of respondents think the US has the most favorable outlook for profits, a 17-year high; all other regions have net negative profit outlooks   ·       A record 42% of investors surveyed say companies are over levered, far exceeding the 32% peak in 2008; overall an all-time high of net 34% think corporate balance sheets are overleveraged    ·       June rotation shows investors are selling cyclical plays (banks, emerging markets and Eurozone equities) in favor of defensive sectors and US equities   ·       When asked what catalyst is most likely to stop Fed tightening, 69% of investors surveyed state domestic reasons (lower inflation, higher unemployment, Fed independence); 23% cited emerging market contagion or a debt crisis in the peripheral EU   ·       This month, the most commonly cited tail risk to the markets is a trade war (31%), followed by a Fed/ECB hawkish policy mistake (26%) and a Euro/EM debt crisis (23%); trade tensions have been the dominant macro concern for investors in 2018   ·       Allocation to commodities hits a new 8-year high, rising 1ppt to net 7% overweight, the highest since April 2012 when WTI was $105/bbl   ·       “Long FAANG+BAT” remains the most crowded trade identified by investors for the fifth straight month and most crowded trade outright since “Long USD” in January 2017; the top three in June are rounded out by “Short US Treasuries” (16%) and “Long USD” (9%)    ·       Expectations for faster global growth hold steadywith just net 1% of investors indicating they think the global economy will strengthen over the next 12 months, barely above the boom/bust threshold and still at their lowest level since February 2016  

The markets ended higher on Tuesday, following the US-North Korea summit in Singapore which ended on a positive note. The S&P BSE Sensex ended at 35,693, up 209 points while the broader Nifty50 index settled at 10,843, up 56 points. Among sectoral indices, the Nifty Pharma index ended over 2.5% higher led by a rise in the shares of Lupin, Dr. Reddy's Laboratories and Glenmark Pharmaceuticals.   United States President Donald Trump on Tuesday said his one-on-one meeting with North Korean leader Kim Jong-un was "very, very good" and they have an ...

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient – Pay as you go
Pay using Credit Cards and select Debit Cards (Issued by ICICI Bank only)
Auto renewed (subject to your card issuer’s permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.
  • Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers of their products and services.
  • This is an optional offer - Not comfortable with sharing personal data - please opt for the full price offer which requires you to share minimal information

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

BS Digital + FREE Monthly access to The Wall Street Journal online

Business Standard Digital - 1 Month + FREE 1 Month access to
The Wall Street Journal online*
199.00
subscribe
FREE across device access to The Wall Street Journal online*
Convenient – Pay as you go
Pay using Credit Cards and select Debit Cards (Issued by ICICI Bank only)
Auto renewed (subject to your card issuer’s permission)
Cancel any time in the future
Exclusive invite to select Business Standard events.

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

ON THE wall street journal online

  • Seamless access to The Wall Street Journal online on any device with your Business Standard Digital account.
  • Experience the best of WSJ’s reporting, video and interactive features (More business executives read the journal globally than any other publication).
  • Get WSJ’s take on people and events shaping business, finance, technology, politics and culture.
  • Get WSJ newsletters in your inbox to make life easier on your busiest days.
  • Your access to The Wall Street Journal online is subject to you not being an existing user of The Wall Street Journal online. Existing users include current or past Premium Users of The Wall Street Journal online. If you happen to be one, your subscription will be valid for Business Standard Digital only without any change in the subscription price.

NOTE :

  • This product is a monthly auto renewal product.
  • If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly  email us your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART ANNUAL

BS Digital + Free 12 Month Access to The Wall Street Journal online

Business Standard Digital - 12 Months + FREE 12 Months access to The Wall Street Journal online*
1999.00
subscribe
Get 12 months of The Wall Street Journal online worth Rs 17165 FREE*
Single Seamless Sign-up to Business Standard Digital and The Wall Street Journal online
Convenient - Once a year payment
Pay using Credit or Debit Card
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

ON THE wall street journal online

  • Seamless access to The Wall Street Journal online on any device with your Business Standard Digital account.
  • Experience the best of WSJ's reporting, video and interactive features (More business executives read the journal globally than any other publication).
  • Get WSJ's take on people and events shaping business, finance, technology, politics and culture.
  • Get WSJ newsletters in your inbox to make life easier on your busiest days.
  • Your access to The Wall Street Journal online is subject to you not being an existing user of The Wall Street Journal online. Existing users include current or past Premium Users of The Wall Street Journal online. If you happen to be one, your subscription will be valid for Business Standard Digital only without any change in the subscription price.

NOTE :

  • Saving calculated at the current WSJ price - US $ 1 for the first 3 months and US $ 28.99 thereafter Conversion scale 1 US$ = 65.04 INR
  • If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly  email us your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART ANNUAL

Business Standard Digital

Business Standard Digital - 12 Months
1999.00
subscribe
Pay as you go
Payment though credit card only
Auto renewed (Subject to your card issuer's permission)
Exclusive invite to select Business Standard events
Cancel any time in the future

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to  assist@bsmail.in Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.
First Published: Tue, June 12 2018. 15:30 IST
RECOMMENDED FOR YOU

MARKET WRAP: Sensex ends 209 pts up, Nifty at 10,843 post Trump-Kim meeting

Among sectoral indices, the Nifty Pharma index ended over 2.5% higher led by a rise in the shares of Lupin, Dr. Reddy's Laboratories and Glenmark Pharmaceuticals.

The markets ended higher on Tuesday, following the US-North Korea summit in Singapore which ended on a positive note. The S&P BSE Sensex ended at 35,693, up 209 points while the broader Nifty50 index settled at 10,843, up 56 points. Among sectoral indices, the Nifty Pharma index ended over 2.5% higher led by a rise in the shares of Lupin, Dr. Reddy's Laboratories and Glenmark Pharmaceuticals.   United States President Donald Trump on Tuesday said his one-on-one meeting with North Korean leader Kim Jong-un was "very, very good" and they have an ...

image
Business Standard
177 22